USP5 and lung cancer: In the cohorts analyzed in this study, 24.6% of the lung cancer cases exhibited high levels of USP5 expression/Wnt signaling/stemness, while 23.4% of the lung cancer cases had low levels, indicating that this pathway exists in patients with lung cancer (Fig. 6B).